STOCK TITAN

Celestica, Inc. Form 4 Filings

CLS NYSE

Every Form 4 that Celestica, Inc. (CLS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLS filings page.

Rhea-AI Summary

Celestica Inc. President Jason Phillips reported several equity award transactions in early February 2026. On February 2, 2026, 174,254 performance share units and 7,382 restricted share units were exercised at $0, converting into common shares, with some shares then withheld at $280.99 per share to cover tax obligations. Following these movements, he directly held 112,658 common shares. On February 3, 2026, he received a new grant of 4,209 restricted share units, each representing a contingent right to one common share or cash, vesting ratably over three years.

Rhea-AI Summary

Celestica Inc. Chief Operations Officer Yann L. Etienvre reported multiple equity transactions dated February 2–3, 2026. He exercised 160,126 performance share units into the same number of common shares at an exercise price of $0 and 6,829 restricted share units into common shares.

To cover tax withholding on these vestings, 77,421 and 3,305 common shares were withheld at $287.45 per share. He then sold 82,705 and 3,524 common shares at $287.45 per share, leaving no common shares from those lots. On February 3, 2026, he also received a new grant of 4,209 restricted share units, each representing a contingent right to one common share or cash.

Rhea-AI Summary

Celestica Inc.'s Chief Financial Officer, Mandeep Chawla, reported equity compensation activity involving performance share units (PSUs), restricted share units (RSUs), and common shares. On February 2, 2026, 183,674 PSUs and 7,382 RSUs were exercised into common shares at an exercise price of $0.

To cover related tax withholding, 98,321 common shares at $279.78 and 3,952 common shares at $280.99 were withheld, leaving 98,266 common shares directly owned after these transactions. The 183,674 PSUs were earned at 200% of target after committee certification and vested on January 31, 2026.

On February 3, 2026, Chawla was also granted 4,630 new RSUs, each representing a contingent right to one common share or cash, vesting ratably over three years on the first and second anniversaries of the grant date and on the December 1 following the second anniversary.

Rhea-AI Summary

Celestica Inc. President Todd C. Cooper reported multiple equity compensation transactions in early February 2026. He exercised 160,126 performance share units and 6,644 restricted share units, receiving an equal number of common shares at an exercise price of $0 per share.

To cover tax withholding from vesting of RSUs and PSUs, 74,203 and 3,083 common shares were withheld at $287.45 per share. He also sold 85,923 and 3,561 common shares at $287.45 per share. After these transactions he directly held 108,970 common shares.

Separately, on February 3, 2026 he was granted 3,227 new restricted share units, each representing a right to one common share or cash, vesting ratably over three years.

Rhea-AI Summary

Celestica Inc. Chief Executive Officer and director Robert Mionis reported a series of equity award events. On February 2, 2026, 780,376 performance share units were exercised into the same number of common shares after the compensation committee certified performance at 200% of target, and 33,684 restricted share units were also exercised into common shares.

On the same date, 307,078 and 13,255 common shares were withheld to cover tax obligations from these vestings at a price of $280.99 per share, leaving Mionis with 1,002,733 common shares held directly. Separately, on February 3, 2026, he received a new grant of 23,009 restricted share units, which vest ratably over three years. Following these transactions, he also holds 33,684 and 23,009 restricted share units, each representing a contingent right to receive one common share or cash.

Rhea-AI Summary

Celestica Inc. reported an equity award for its President, Todd C. Cooper. On January 29, 2026, he was credited with 160,126 performance share units at a price of $0 per unit. Each PSU represents the right to receive one common share or the cash equivalent.

The award reflects PSUs deemed earned after the Human Resources and Compensation Committee certified achievement of pre-set performance goals at 200% of target. The common shares underlying these PSUs are scheduled to be issued to Cooper following vesting on January 31, 2026.

Rhea-AI Summary

Celestica Inc. reported that Chief Human Resources Officer Leila Wong received a grant of 61,224 performance share units (PSUs) on January 29, 2026. Each PSU represents a contingent right to receive one common share or an equivalent cash value, depending on settlement.

The PSUs were deemed earned after the Human Resources and Compensation Committee certified achievement of pre-established performance goals at 200% of target. The common shares underlying these PSUs are scheduled to be issued to Wong following vesting on January 31, 2026.

Rhea-AI Summary

Celestica Inc. president Jason Phillips reported an award of 174,254 performance share units (PSUs) on January 29, 2026. Each PSU represents a contingent right to receive one common share or an equivalent cash amount, at no stated exercise price.

The PSUs were deemed earned after the Human Resources and Compensation Committee certified achievement of pre-established performance goals at 200% of target. The underlying common shares are scheduled to be issued to Phillips following the vesting date on January 31, 2026, and are held as a direct ownership position.

Rhea-AI Summary

Celestica Inc.'s Chief Operations Officer Yann L. Etienvre received a performance-based equity award. On January 29, 2026, he was granted 160,126 Performance Share Units at a price of $0 per unit, all held as direct beneficial ownership.

Each PSU represents the right to receive one common share or an equivalent cash amount. The award reflects achievement of pre-set performance goals at 200% of target, as certified by the Human Resources and Compensation Committee. The common shares underlying these PSUs are scheduled to be issued to Etienvre after they vest on January 31, 2026.

Rhea-AI Summary

Celestica Inc.’s Chief Financial Officer, Mandeep Chawla, reported an award of derivative securities in the form of performance share units (PSUs). On January 29, 2026, he acquired 183,674 PSUs at a price of $0 per unit, held as direct ownership.

Each PSU represents a contingent right to receive one common share of Celestica or an equivalent cash value. These PSUs were deemed earned after the Human Resources and Compensation Committee certified that pre-established performance parameters were achieved at 200% of target. The common shares underlying these PSUs are scheduled to be issued to Chawla following vesting on January 31, 2026.

Rhea-AI Summary

Celestica Inc. reported that Chief Executive Officer and director Robert Mionis was granted 780,376 performance share units (PSUs) on January 29, 2026.

Each PSU represents a contingent right to receive one common share or an equivalent value in cash. The PSUs were deemed earned after the Human Resources and Compensation Committee certified achievement of pre-established performance parameters at 200% of the target, and the common shares underlying these PSUs are scheduled to be issued to Mionis following vesting on January 31, 2026.

Rhea-AI Summary

Celestica director Luis A. Muller reported an equity award of 37 restricted share units (RSUs) on January 28, 2026. Each RSU represents a right to receive one common share or an equivalent cash amount, and these RSUs vest upon his retirement on that same date.

Rhea-AI Summary

Celestica Inc. reported that one of its directors acquired additional equity-linked compensation in the form of director share units. On 12/31/2025, the director received 237 director share units, recorded as an acquisition with a price of $0 per unit. According to the filing, each director share unit represents a contingent right to receive one common share or an equivalent value in cash, at the company’s discretion, when the holder ceases to serve Celestica as a director, consultant or other service provider.

Following this transaction, the director beneficially owns 444 derivative securities related to Celestica common shares, held in direct form. The disclosure highlights how the director’s economic exposure to the company’s equity is structured through these deferred units rather than immediate share ownership.

Rhea-AI Summary

Celestica Inc. reported a routine insider equity award for one of its directors. On 12/31/2025, the director received 237 director share units, which are a type of derivative security tied to Celestica common shares. These units were granted at a price of $0 and increase the director’s holdings to 992 derivative securities after the transaction.

Each director share unit represents a contingent right to receive one Celestica common share, or an equivalent cash amount, at the company’s discretion when the holder stops serving as a director, consultant, or other service provider. The filing indicates the director’s ownership is held directly and reflects standard equity-based compensation rather than an open‑market purchase or sale.

Rhea-AI Summary

Celestica Inc. director reports acquisition of additional director share units. A board member of Celestica Inc. (CLS) filed a Form 4 disclosing that on 12/31/2025 they acquired 267 director share units. These units carry no exercise price and represent the right to receive an equal number of common shares, or an equivalent cash amount, when the holder stops serving Celestica as a director, consultant or other service provider, at the company’s discretion. Following this transaction, the reporting person beneficially owns 1,116 derivative securities (director share units) on a direct basis.

Rhea-AI Summary

Celestica Inc. reported an insider equity award for one of its directors. On 12/31/2025, the director acquired 170 director share units at a price of $0, reported as a derivative security. After this transaction, the director beneficially owned 170 director share units on a direct basis. Each director share unit represents a contingent right to receive one common share of Celestica, or an equivalent value in cash at the company’s discretion, when the holder ceases to serve the issuer as a director, consultant, or other service provider.

Rhea-AI Summary

Celestica IncDecember 31, 2025, the reporting person was granted 237 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash amount at the holder's election. The RSUs were reported as derivative securities beneficially owned in direct form.

The award vests over time, with one-third of the 237 RSUs vesting annually over three years on the anniversary of the grant date. This type of grant is a standard form of non-cash compensation that aligns a director’s interests with those of shareholders by linking part of their compensation to the company’s share performance.

Rhea-AI Summary

Celestica Inc. reported an equity compensation transaction by one of its directors on a Form 4. On 12/31/2025, the director acquired 127 director share units, listed as derivative securities with a price of $0, reflecting a grant rather than an open-market purchase.

After this transaction, the director beneficially owns 531 director share units, held directly. According to the disclosure, each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the company’s discretion, when the holder stops serving as a director, consultant or other service provider. This filing highlights ongoing alignment of director compensation with shareholder interests through share-based awards.

Rhea-AI Summary

Celestica Inc. director reports grant of restricted share units

A director of Celestica Inc. (CLS) filed a Form 4 disclosing an equity award dated December 31, 2025. The reporting person received 129 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the holder's election.

According to the disclosure, one-third of the 129 RSUs vests annually over three years on the anniversary of the grant date. This filing reflects routine equity-based compensation for a board member rather than an open‑market purchase or sale of Celestica shares.

Rhea-AI Summary

Celestica Inc. director reports receipt of equity-based compensation. A company director filed a Form 4 showing the acquisition of 118 director share units on 12/31/2025. These units are derivative securities that each represent a contingent right to receive one common share or an equivalent cash value, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.

Following this transaction, the director beneficially owns 495 director share units in total, held directly. The transaction was coded as an acquisition at a stated price of $0, indicating it is part of the director’s compensation rather than an open-market purchase.

Rhea-AI Summary

Celestica Inc. director reports equity award activity and share withholding. A director of Celestica Inc. (CLS) reported several transactions dated 12/31/2025. The filing shows 4,266 common shares acquired at a stated price of $0 and 2,049 common shares disposed of at $299.45 to satisfy tax withholding on vested restricted share units (RSUs), leaving 18,547 common shares held directly.

Derivative tables show RSUs being exercised into common shares and director share units being credited. RSU grants made on December 31 of 2022, 2023, and 2024 each vest in three equal annual installments, and each RSU represents a contingent right to receive one common share or cash at the holder’s election. Director share units each represent a contingent right to receive one common share or cash when the holder ceases serving the company.

Rhea-AI Summary

Celestica Inc. (CLS) Chief Legal Officer filed an amended Form 4 to report an equity award. On February 4, 2025, the reporting person received 2,317 restricted share units (RSUs), each representing a right to one common share or cash of equal value at the holder's election. These RSUs vest in two equal installments on February 4, 2026 and February 4, 2027. The amendment corrects the earliest transaction date and adds this previously omitted RSU grant, while all other information from the original filing remains unchanged.

Rhea-AI Summary

Celestica Inc. Chief Financial Officer insider activity shows routine equity compensation events reported on a Form 4. On 12/01/2025, the CFO acquired 20,408 common shares through the vesting and settlement of previously granted restricted share units at an exercise price of $0. On the same date, 10,925 common shares were disposed of at $344.41 per share to cover tax withholding obligations arising from the RSU vesting, leaving the reporting person with 9,483 common shares held directly.

The derivative table shows 20,408 restricted share units exercised into common shares, reducing the reporting person’s RSU balance to zero for that grant. The filing notes that each RSU represents a contingent right to receive one common share or an equivalent cash amount, and that the original grant of 61,224 RSUs from 01/31/2023 vests in three installments over a three-year period.

Rhea-AI Summary

Celestica Inc.'s Chief Human Resources Officer reported several equity transactions in company common shares on 12/01/2025. The officer acquired 6,802 common shares at an exercise price of $0 through the vesting and settlement of restricted share units (RSUs), increasing directly held shares before subsequent transactions.

To cover tax withholding arising from the RSU vesting, 3,642 shares were withheld and disposed of at $323.38 per share, and an additional 3,160 shares were sold at the same price. After these transactions, the officer directly owned 13,892 common shares and held no remaining RSUs from this grant.

Rhea-AI Summary

Celestica Inc. reported an insider equity transaction by its President. On 12/01/2025, the officer acquired 17,792 common shares through the vesting and settlement of restricted share units at an exercise price of $0, increasing directly held shares. On the same date, 8,248 common shares were disposed of at $344.41 per share to cover tax withholding obligations tied to the RSU vesting. Following these transactions, the officer directly owned 108,970 common shares. The underlying RSU award covered 17,792 common shares and was fully settled, leaving no derivative securities from that grant outstanding.

Rhea-AI Summary

Celestica Inc. Chief Operations Officer reports RSU vesting, tax withholding, and share sale. On 12/01/2025, 17,792 common shares were acquired at an exercise price of $0 upon the vesting and settlement of restricted share units (RSUs). On the same date, 8,605 of these shares were disposed of at $323.38 per share to cover tax withholding obligations, and 9,187 shares were sold in a market transaction at $323.38 per share, leaving 0 common shares held directly after these transactions.

These activities relate to an RSU grant of 53,375 units awarded on January 31, 2023, which vests ratably over three years, including on December 1 following the second anniversary of the grant date. Each RSU represents a contingent right to receive one common share or an equivalent cash amount at the holder’s election.

Rhea-AI Summary

Celestica (CLS) reported a director’s open‑market purchases on 10/30/2025. The filing lists four buy transactions totaling 6,000 common shares, at weighted average prices of $339.68 (700 shares), $340.55 (600), $341.96 (3,227), and $342.44 (1,473). Following these trades, the director beneficially owns 6,000 shares, held directly. No derivative securities were reported.

Rhea-AI Summary

Luis A. Muller, a director of Celestica Inc. (CLS), reported acquisition of 325 director share units on 09/30/2025. These units are a contingent right to receive one common share each or an equivalent cash value when the holder stops serving as a director, consultant or other service provider. After the reported transaction, Mr. Muller beneficially owns 849 common shares directly. The Form 4 was signed on behalf of the reporting person by attorney-in-fact Tracy Connelly McGilley on 10/01/2025. The filing lists the reporting persons address as 5140 Yonge Street, Suite 1900, Toronto, M2N 6L7.

Rhea-AI Summary

Maletira Amar, a director of Celestica Inc. (CLS), acquired 289 director share units on 09/30/2025. Each unit is a contingent right to receive one common share or cash equivalent when the holder ceases to serve the issuer as a director, consultant, or service provider. The reported transaction shows 755 common shares beneficially owned following the award. The units carry no purchase price ($0) and were reported on Form 4 with a signature executed by an attorney-in-fact on 10/01/2025.

Rhea-AI Summary

Celestica director Francoise Colpron received 155 director share units on 09/30/2025, increasing her direct beneficial ownership to 404 common shares. Each director share unit is a contingent right to one common share or cash equivalent at the issuer's discretion when the holder stops serving as a director or other service provider. The units were granted at no cash price and are recorded as an acquisition on Form 4. The filing was signed by an attorney-in-fact on 10/01/2025. This disclosure reflects a routine equity grant to a non-employee director rather than an open-market purchase.

Rhea-AI Summary

Robert Cascella, a director of Celestica Inc. (CLS), was granted 157 restricted share units (RSUs) on 09/30/2025. Each RSU represents a contingent right to one common share or equivalent cash at the holder's election. The grant vests one-third annually over three years beginning on the anniversary of the grant. Following the grant the reporting person beneficially owns 157 common shares (direct). The RSUs were granted at a $0 per-unit price (no cash paid by the reporting person) and are subject to the stated vesting schedule.

Rhea-AI Summary

Celestica Inc. director Kulvinder Ahuja received 144 director share units on 09/30/2025 under a non‑derivative award that vests to one common share (or cash equivalent) when the holder ceases service. The reported acquisition shows a $0 price per unit, and following the grant Ahuja beneficially owns 377 common shares in direct form. The filing was submitted on 10/01/2025 and signed by an attorney‑in‑fact. The director share unit plan creates a contingent right to receive common shares or cash at termination of service.

Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple awards and acquisitions on 06/30/2025. The Form 4 shows a direct acquisition of 5,890 common shares (transaction code M) at $0, increasing his direct beneficial ownership to 13,391 shares. The filing also reports vesting/awards of restricted share units (RSUs) totaling 5,890 RSUs across grants from 2022–2024 and 671 director share units granted/recorded, with underlying common-share equivalents and post-transaction holdings listed for each tranche.

The RSU grants are subject to time-based vesting schedules (one-third annually) as described for grants dated June 30 of 2022, 2023 and 2024. The Form 4 was signed by an attorney-in-fact, Tracy Connelly McGilley, on 07/01/2025.

Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported transactions dated 03/31/2025 on Form 4. The filing shows an acquisition of 5,717 common shares (transaction code M) resulting in 7,501 common shares beneficially owned directly after the reported non-derivative transaction. The filing also records multiple equity award movements: RSU grants or vesting events of 2,517, 2,440, and 760 restricted share units (RSUs) and an acquisition of 1,300 deferred share units (DSUs). The explanatory notes clarify each RSU and DSU represents a contingent right to receive one common share or cash equivalent under specified conditions.

Rhea-AI Summary

Insider sale and filing correction at Celestica (CLS). The Form 4 shows director Michael Max Wilson sold 25,000 common shares on 01/06/2025 at a weighted average price of $98.73 per share (price converted from CAD). After the disposition the report shows 1,784 shares beneficially owned directly. The filing also corrects prior reporting by including 9,117 shares that were omitted from a Form 3 filed 12/19/2024. The transaction was signed by an attorney-in-fact on 01/08/2025.

Rhea-AI Summary

Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple equity award transactions on Form 4 dated 12/31/2024. The filing shows an acquisition of 6,697 common shares (code M) resulting in 17,667 shares beneficially owned after the transaction. The report also lists several restricted share unit (RSU) transactions: purchases/acquisitions of 2,795, 2,735, 1,167, and 1,092 RSUs on 12/31/2024, with corresponding beneficial ownership counts shown as 0, 2,736, 2,333, and 1,092 common shares respectively. The explanatory notes confirm the RSUs were annual grants from 2021 through 2024 and vest one-third annually over three years.